Global Heart Hub Annual Review

2023 Annual Review

2023 was a year that marked a significant milestone in our journey. During the year, we were delighted to welcome our 100th international patient organisation affiliate. Our growing network of patient organisations and individual advocates is a testament to our collective dedication and unwavering commitment to strengthening the patient voice as an equal stakeholder in healthcare and advocating for the best possible outcomes for those living with or affected by heart disease and its connected conditions.

We extend our heartfelt thanks to each of our affiliates and supporters. Your collaboration, partnership and collective commitment to our shared vision of an empowered, activated and engaged patient community is what drives us. Thank you for being an integral part of the Global Heart Hub community.

2022 Annual Review

Throughout 2022, we worked closely with our affiliates, who now number almost 100 patient organisations and operate in 30 countries. Together, we have made great strides in strengthening and supporting the patient voice and in advocating for the needs of those living with or affected by heart diseases. In this annual review we are delighted to share with you the highlights from our many activities and initiatives over the past year. Our patient councils and working groups developed and led several international disease awareness campaigns; engaged in a number of capacity and capability training and development activities and implemented numerous advocacy initiatives at national and regional levels across the world.

Inaugural Report, 2020 & 2021

We are delighted to share our inaugural report, covering our 2020 and 2021 activities. Over the past two years, we have begun building an international community of connected and engaged patients. We are committed to raising awareness of the many unmet patient needs across the patient journey from disease awareness, through detection, diagnosis, treatment and recovery. We are committed to supporting patients and patient organisations to build their capacity and capability to engage as equal stakeholders in healthcare decision making, healthcare policy and addressing healthcare inequalities in access to new and innovative treatments and technologies.